Lidokain Belupo

Lidocaine, the active ingredient in Lidokain Belupo, is a local anesthetic presented as a solution for oromucosal use. It works by blocking nerve impulse transmission, providing rapid and reversible loss of sensation in the oral mucosa, which is useful for dental treatments, minor oral surgeries, and diagnostic procedures. It is commonly employed by oral surgeons and dentists to improve patient comfort during procedures.

GNH USA supplies Lidokain Belupo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable global logistics.

Lidokain Belupo (lidocaine) is used for local anesthesia of the oral mucosa and related procedures.

- Dental procedures: provides temporary numbness of the gums and oral tissues to facilitate extractions, restorations, and scaling. - Oral surgery: enables pain‑free access for minor surgical interventions such as biopsies or frenectomies. - Mouth ulcer treatment: reduces discomfort associated with aphthous ulcers or traumatic lesions. - Diagnostic examinations: allows painless probing or impression taking during oral examinations.

Lidokain Belupo may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Altered taste sensation: temporary metallic or bitter taste. - Local irritation: mild burning or stinging at the application site. - Nausea or mild gastrointestinal upset. - Dizziness or light‑headedness. - Headache. - Mild swelling of the oral mucosa.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Central nervous system toxicity: seizures or convulsions. - Cardiovascular effects: arrhythmias, hypotension, or cardiac arrest. - Severe local tissue necrosis. - Persistent numbness beyond the expected duration.

When using Lidokain Belupo, consider the following safety measures.

- Allergy assessment: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Dose limitation: avoid exceeding recommended application amounts to reduce systemic absorption. - Cardiac caution: use with care in patients with existing heart disease or conduction abnormalities. - Hepatic function: monitor patients with severe liver impairment as metabolism may be reduced. - Methemoglobinemia monitoring: watch for cyanosis or shortness of breath, especially with extensive use. - Store at room temperature: keep in the original container, protect from moisture and light.

Lidokain Belupo can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increased risk of cardiotoxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): elevated lidocaine plasma levels. - Other amide‑type local anesthetics: additive systemic toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask early signs of lidocaine toxicity. - Diuretics: can affect plasma protein binding, altering free drug concentration. - General anesthetics (e.g., propofol, volatile agents): may potentiate central nervous system depression.